Introduction
Iron is an important micronutrient for virtually all living organisms, except lactic acid bacteria where manganese and cobalt are used in place of iron. Under aerobic conditions, free iron abundance is limited by the very low solubility of ferric hydroxide. 1 It acts as a cofactor for the redox-dependent enzymes involved in most cellular processes, including electron transfer, RNA synthesis, and resistance to reactive oxygen intermediates. 2 Under physiological conditions, iron can exist in either the reduced ferrous form (Fe 2+ ) or the oxidized ferric form (Fe 3+ ). The redox potential of Fe 2+ /Fe 3+ makes iron extremely versatile when it is incorporated into proteins as a catalytic center or as an electron carrier. 3 Bacteria have developed various ways to circumvent an iron shortage, 4, 5 and these generally rely on receptor proteins at the bacterial surface that bind specifically to a wide range of ironcontaining molecules. For many pathogens, these ligands can be the iron-binding proteins that the host itself uses to keep Fe 3+ in solution (e.g., transferrin), whereas others produce hemophores.
To overcome the iron-restricted condition in their mammalian hosts, coliform bacteria may utilize one or more iron assimilation systems to take up iron within a particular environmental niche in the host. 4 Possession of iron uptake systems is known to be important in bacterial pathogenesis. High-affinity iron uptake systems are widely utilized by coliform bacteria to take up iron in the host milieu. These involve the synthesis of a low molecular mass siderophore, the expression of iron-regulated outer membrane proteins (IROMPs) and enzymes to utilize the chelated iron. 4 Gram-negative bacteria take up ferricsiderophore complexes via specific outer membrane (OM) receptors in a process that is driven by the cytosolic membrane (CM) potential and mediated by the energy-transducing TonBExbB-ExbD system. Periplasmic binding proteins shuttle ferricsiderophores from the OM receptors to CM ATP-binding cassette (ABC) transporters, which in turn deliver the ferric-siderophores to the cytosol where the complexes are probably dissociated by reduction. 6 Escherichia coli excrete the catecholate siderophore enterobactin in response to iron deprivation, to solubilize iron prior to transport. Ferric enterobactin protein (FepA) is a Gram-negative bacterial OM protein that transports ferric enterobactin. FepA from E. coli is a 724-residue integral OM protein that transports ferric enterobactin into the periplasm. FepA is composed of two domains: (1) a 22-stranded antiparallel b-barrel, spanning the OM, with connecting loops (residues 154-724); and (2) an N-terminal globular domain consisting of two long loops, several short bstrands and single-turn helices (residues 1-153) that fold into the barrel, plugging the barrel pore. The b-barrel domain has the following three main features: 10 short periplasmic loops that range in length from 2 to 10 residues, the 22-strand b-barrel, and 11 extracellular loops. The lengths of these extracellular loops can range from 2 to 37 residues, consequently comprising roughly 40-50% of the total b-barrel. The extracellular loops can extend 30-40 Å above the OM. Their presumed role is to initially interact with the ferric-siderophore as well as occlude the opening of the bbarrel to prevent the access of unwanted solutes. 7 These data support the idea that the production of antibody against FepA may contribute to protection against Gram-negative bacteria 8 with higher fepA gene homologies. On the basis of the above criteria the present work was designed focusing on the cloning and expression of the fepA gene and studying the immunoactivity of its recombinant protein.
Materials and methods

Chemicals and enzymes
T4 DNA ligase was purchased from Fermentas (Vilnius, Lithuania). Restriction endonucleases were obtained from Cinnagen (Tehran, Iran). All other chemical reagents were from Sigma (Munich, Germany) or Merck (Darmstadt, Germany). The gel purification kit and plasmid extraction kit were from Bioneer (Daejeon, Korea). Nickel-nitrilotriacetic acid (Ni-NTA) agarose was from Qiagen (Valencia, USA). Primers were synthesized by Bioneer .
2.2. Bacterial strains, plasmids, and culture media E. coli Ol57:H7 (ATCC 43889), Shigella flexneri (NTCC 12678), Klebsiella pneumoniae (ATCC 13883), and Salmonella typhi (PTCC 1609) were used. The plasmid pET28a(+) was a Novagen product (USA). E. coli BL21(DE3) was purchased from Cinagen (Iran). E. coli strains were cultivated in Luria-Bertani (LB) broth or LB agar at 37 8C. E. coli transformants were grown on LB medium containing 50 mg/ml ampicillin.
Construction of plasmid
The gene coding for ferric enterobactin binding protein (fepA) from E. coli Ol57:H7 was amplified from its genomic DNA via PCR. The forward (5 0 -TAAAGGATCCATGAACAAGAAGATTC-3 0 ) and reverse (5 0 -AGCAGTCGACGAAGTGAGTGTTTAC-3 0 ) primers were used to amplify the fepA gene with the stop codon truncated in order to be fused with a downstream His-tag sequence on the vector (BamH1and SalI restriction enzyme sites underlined). PCR conditions consisted of 5 ml (50 ng/ml) DNA, 1 ml of each primer (20 pM), 250 mM each dNTP, 40 mM KCl, 40 mM MgCl, and 1 ml of 2.5 U Taq DNA polymerase in a final volume of 50 ml on a thermal cycler (Techne Gradient, Staffordshire, UK). The PCR procedure was as follows: initial denaturation at 948 C for 5 min and 35 cycles of 1 min at 94 8C, 1 min at 55 8C, 3 min at 72 8C, followed by an additional 5 min at 72 8C. The amplified DNA products were electrophoresed in a 0.8% (w/v) agarose gel. The PCR products (2241 bp for fepA) were purified using a PCR purification kit as per the manufacturer's instructions. The PCR product was digested with BamH1 and SalI and cloned into pET28a(+) vector digested with the same endonucleases. The new construct was named pET28a-FepA. The recombinant DNA was transformed into E. coli strain BL21(DE3) as an expression host. The transformants were selected on LB agar containing 50 ng/ml ampicillin. After mini-scale isolation of the plasmid DNA using the plasmid extraction kit, the presence of the open reading frame (ORF) was confirmed by restriction analysis and by sequencing.
Expression and purification of FepA protein
A single bacterial colony was used to inoculate 5 ml of LB broth containing 50 mg/ml ampicillin. The culture was shaken at 200 rpm at 37 8C overnight and was then used to inoculate 100 ml of LB broth with 50 mg/ml ampicillin in a 500 ml flask. At the optical density of 0.6 at 600 nm, 1 mM isopropyl b-D-thiogalactoside (IPTG) was used for induction . The culture was further shaken at 37 8C for 4 h and was then harvested by centrifugation at 5000 rpm at 4 8C for 10 min. The pellets were suspended in phosphate-buffered saline (PBS, pH 7.4) and boiled at 100 8C for 5 min with the sample buffer solution. The recombinant FepA was purified by Ni-NTA affinity chromatography. The cell pellet was thawed at 4 8C and resuspended in lysis buffer, followed by the addition of lysozyme at 1 mg/ml; it was then incubated on ice for 30 min. The lysate was then sonicated (6 times, 10 s at 200 W with a 10 s cooling period between each burst) using a sonicator equipped with a microtip. The lysate was then centrifuged at 8500 rpm for 25 min at 4 8C to pellet the cellular debris. The supernatant was loaded onto an Ni-NTA agarose column, preequilibrated with 5 ml lysis buffer containing 10 mM imidazole. The FepA protein was eluted by a stepwise procedure, using buffers containing 20, 40, 90 and 150 mM imidazole. The fractions were collected and analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The protein fractions pool was concentrated by freeze-drying. Protein concentration was determined by the method of Lowry et al. 9 using bovine serum albumin (BSA) as a standard.
Western blot analysis
Protein samples were electrophoresed on a 9% SDS-PAGE gel and then electroblotted onto a nitrocellulose membrane at a constant current of 300 mA at 4 8C for 1.5 h. The membrane was incubated in the blocking buffer of 3% BSA, with gentle shaking for 1 h at room temperature. The membrane was then washed 3 times with PBS-T (PBS + 0.05% Tween-20, pH 7.4) before incubation with the diluted mouse anti-FepA (1:100) serum for 1 h. After the PBS-T wash, the membrane was incubated with mouse IgG conjugated with horseradish peroxidase (HRP) for 1 h at room temperature. The membrane was then washed three times in PBS-T. The membrane was visualized with diaminobenzidine (DAB) substrate until brownish bands were observed. Color development was then terminated by washing in PBS.
Immunization of mice
Male inbred BALB/c mice, 4-6 weeks old (16-22 g), were procured from the Pasteur Institute, Tehran, Iran. Animals were kept in well aerated rooms and were fed on a standard pellet diet and water. Mice were acclimatized to the laboratory conditions for 1 week before use in the experiments. The recombinant protein was emulsified with complete Freund's adjuvant. A total of 40 BALB/c mice were immunized with 10 mg of recombinant protein per mouse on days 0, 15, 30 and 45, intraperitoneally by injecting 0.2 ml of antigen/adjuvant mixture under mild analgesia. Blood samples were collected 10 days post-injection through infra-orbital route. An additional 10 BALB/c mice served as a control group.
Analysis of antibody response
Sera were assayed for an antibody response against the recombinant protein by ELISA. Briefly, 96-well microtiter plates were coated with 2 mg purified recombinant FepA protein. Serial dilutions of each serum ranging from 1:400 to 1:51 200 were added to the wells in triplicate. Antibodies binding to the antigen were detected using anti-mouse IgG conjugated with HRP at 1:2000 dilution. The color was developed with orthophenylenediamine (OPD) for 30 min and the reaction was stopped with 2 M H 2 SO 4 . The plates were then read with a microplate reader at 492 nm. Results were considered positive if the absorbance was at least double that of the control sera and the antibody titers were scored as the highest positive dilution. 10 
Determination of bacterial lethal dose (LD 50 )
E. coli O157:H7, S. flexneri, K. pneumoniae, and S. typhi at doses ranging from 2 Â l0 4 to 2 Â l0 9 CFU/ml were administered intraperitoneally to four groups of BALB/c mice with 10 animals per group. Mortality in the mice was recorded for two consecutive post-challenge days.
Mouse challenge experiment
The immunized and control groups were challenged by intraperitoneal injection with 1 ml of live microbial suspensions at microbial log phase.
Bactericidal assay of anti-FepA antibody
The bactericidal activity of anti-FepA serum raised in mice was assayed by the method given by Chen et al. 11 The complement source for the experiment was fresh human serum from healthy individuals. Serial dilutions of the heat-inactivated anti-FepA serum were prepared. The bactericidal assay was performed by mixing 100 ml of bacterial suspension (approximately 2 Â 10 6 organisms) in PBS (containing 1 mM CaCl 2 and 0.2 mM MgCl 2 ) with 50 ml of heat-inactivated serum and incubating for 30 min at 4 8C. About 30 ml of the complement containing serum was then added (1:10 diluted) to give a final concentration of 20% and the mixture was incubated overnight at 37 8C in 96-well plates. The following morning, the samples from wells were plated on nutrient agar plates and allowed to incubate overnight at 37 8C. The controls for this assay consisted of: (1) bacterial suspension + immune serum + heat-inactivated complement; (2) bacterial suspension + pre-immune serum + fresh complement; (3) bacterial suspension + pre-immune serum + heat-inactivated complement. Colony forming units (CFU) were calculated after incubation of nutrient agar plates and % killing was calculated as follows: ((CFU from control À CFU from sample)/CFU from control) Â 100.
Results
PCR amplification of the fepA gene
The fepA gene of E. coli Ol57:H7 was successfully amplified by PCR and cloned into pET28a(+) vector. This construct was confirmed by restriction enzyme analysis (Figure 1) and by DNA sequencing. The pET28a(+)-FepA was transformed into BL21(DE3) E. coli cells for overexpression of the recombinant FepA with a Cterminal His-tag.
Expression and purification
The recombinant FepA protein was over-produced after IPTG induction. Following His-tagged affinity chromatography, the purified recombinant protein analysis with SDS-PAGE revealed a single band of approximately 85 kDa (Figure 2 ).
Antibody response
Significantly high antibody was detected in the test group by ELISA compared with the control group injected with PBS ( Figure 3 ).
Western blot analysis
The specificity of the recombinant protein was determined by Western blot analysis using FepA protein with antiserum. Production of recombinant FepA protein was reconfirmed in iron-restricted medium. The antibody was specifically reacted with the recombinant protein (Figure 4) . 
Determination of LD 50
The LD 50 of E. coli O157:H7, S. flexneri, K. pneumoniae, and S. typhi for BALB/c mice were determined as 7 Â 10 8 , 4 Â 10 4 , 4 Â 10 4 , and 2 Â 10 4 CFU, respectively. All the mice but the immune ones died within 24-72 h. Postmortem examinations were performed on the dead animals and bacteria were isolated from liver and spleen. The serum of immunized mice was capable of protecting mice from live bacterial challenge (Table 1 ).
Bactericidal assay of anti-FepA antibody
Sera at 1:10 and 1:20 dilutions showed an average of 81.51% and 73.14% bactericidal properties, respectively.
Discussion
It is well established that iron-regulated OM proteins are expressed under iron-deficient growth conditions. In the present study, FepA from E. coli O157:H7 was cloned and purified in order to evaluate its protective potential in the animal model via intraperitoneal route of administration. Vaccination with recombinant FepA derived from the corresponding genes of E. coli O157:H7 strain protected against infection by E. coli and other bacterial strains (Table 1) . A comparative analysis of the lethal dose of E. coli O157:H7 when injected into control and immune mice showed non-lethal in immunized mice. In this study, the serum of immunized mice was capable of protecting mice from live bacterial challenge. The antibody produced by FepA from one bacterial strain could protect the mice against the other three bacteria used in this study. It may be deduced that anti-FepA antibodies have interfered with the iron uptake ability, thereby inhibiting bacterial growth. This is in agreement with Meyer et al. 12 and Pintor et al. 13, 14 who showed the specific block of iron uptake via siderophore and transferrin using polyclonal and monoclonal antibodies against IROMPs of Pseudomonas sp and Neisseria sp, respectively. FepA is conserved between all the strains investigated, with 52-100% identity in the nucleotide and amino acid sequence (data not shown). Hence, FepA, as expected, potentially induced protection against the bacterial strains under study. These results indicate that FepA is likely to induce protection against most Enterobacteriaceae and could be an attractive vaccine candidate.
The bacterial iron limitation inducible OM proteins hold a promise for vaccine development, since they expose a substratebinding domain at the cell surface, which must be conserved for function. 15 If the immune system could be directed against this domain, an effective, broadly cross-reactive vaccine could possibly be developed. In order to practically arrive at such a conclusion, further study of cross-immunity using recombinant FepA derived from each of the pathogens is suggested. The quantitative bacterial counts determined in the bactericidal assay showed an average four-fold decrease in the bacterial counts compared with controls. The 73.14-81.51% bactericidal property obtained emphasizes the role of humoral immunity against E. coli infection. Therefore growth inhibition of the bacterium was accomplished as a result of blocking the uptake of iron. This is in agreement with earlier observations where anti-IROMP antibodies significantly reduced E. coli septicemia and severity of gross lesions in turkeys. 16 The periplasmic extraction of bacterial cells grown in ironrestricted medium showed FepA production, while the cells grown in iron-rich medium did not produce FepA (Figure 4 ). These findings further support the idea that the mechanism of iron uptake may constitute an important virulence factor, which can help in establishing infection in the host. 17 The study of this virulence system may lead to a better understanding of bacterial pathogenesis, especially in pathogens like E. coli. Additional investigations are required to assess the effects of different mouse strains, routes of immunization, and mucosal adjuvants on the types of immune response induced by vaccination with FepA. It will be interesting to further explore the mechanism of FepA protection. In future studies, different immunization procedures, adjuvants, cross-immunity studies using recombinant FepA derived from each of the pathogens, delivery vectors and animal models should be considered to make it applicable in both the human and large animals.
Conclusions
Immunization with FepA protein from E. coli O157:H7 can protect against infection with E. coli O157:H7, S. flexneri, K. pneumoniae, and S. typhi further supporting the use of this antigen as a potential vaccine candidate. Future research will investigate the most effective vaccination schedule for preventing E. coli infections and whether this antigen is more effective in combination with other novel E. coli vaccine candidates. 
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